Nadia Darwish
Researcher
University of Arkansas for Medical Sciences
unknown
Research Areas
Is this your profile? Verify and claim your profile
Biography and Research Information
OverviewAI-generated summary
Nadia Darwish's research investigates therapeutic vaccines for human papillomavirus (HPV) and related conditions. Her work includes a Phase 2 clinical trial of a peptide-based HPV therapeutic vaccine, PepCan, for treating cervical intraepithelial neoplasia (CIN2/3), comparing its efficacy against a Candida adjuvant alone. Darwish has also contributed to studies examining the use of PepCan for reducing head and neck cancer recurrence in a Phase I/II clinical trial. Additionally, her research has explored factors influencing the analysis of gastrointestinal tract microbiota in broiler chickens, including the impact of 16S ribosomal RNA primers and the choice of microbial databases. Her publications also touch upon the temporal dynamics of the chicken mycobiome and the effects of early post-hatch feed access on gastrointestinal development.
Metrics
- h-index: 4
- Publications: 8
- Citations: 95
Selected Publications
- A Randomized Double-Blind Placebo-Controlled Phase I/II Clinical Trial of a Human Papillomavirus Therapeutic Vaccine, PepCan, for Reducing Head and Neck Cancer Recurrence (2026) DOI
- A Randomized Double-Blind Phase 2 Clinical Trial Treating Cervical Intraepithelial Neoplasia 2/3 with PepCan or <i>Candida</i> (2025) DOI
- Immune responses in a phase 2 clinical trial of peptide-based therapeutic human papillomavirus vaccine, PepCan, versus <i>Candida</i> adjuvant alone in treating cervical intraepithelial neoplasia 2/3. (2024) DOI
- A peptide-based human papillomavirus therapeutic vaccine, PepCan, or <i>Candida</i> adjuvant alone in treatment of cervical intraepithelial neoplasia 2/3 (CIN2/3). (2023) DOI
- Temporal dynamics of the chicken mycobiome (2022) DOI
Collaborators
Researchers in the database who share publications
Similar Researchers
Based on overlapping research topics